The Cuban-made synthetic vaccine against the Haemophilus influenzae type B, the first of its kind developed in the world, has been described as a relevant scientific breakthrough.
Experts who attended the 5th International Congress on Chemistry, held in Havana, highlighted the excellent quality of the Cuban vaccine, which was obtained from synthetic antigens.
The product, created by Dr. Vicente Verez, does not contain any component of the bacterium.
In practice, it is a reproduction of the structure of the molecule of the Haemophilus influenza type B, so that it can be recognized by the immune system.
The Cuban vaccine is highly effective to fight the bacterium, against which the body generates a defensive response.
From the industrial viewpoint, it is feasible to increase production of the vaccine, since it poses a lower chemical risk for human health.